FMDV and E2 fusion proteins and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9913891
APP PUB NO 20170143819A1
SERIAL NO

15353727

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC3239 SATELLITE BLVD BLDG 500 DULUTH GA 30096

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Audonnet, Jean-Christophe Lyons, FR 39 173
Bomchil, Natalia Lyons, FR 3 5
Reynard, Frédéric St Bonnet-de-Mure, FR 4 6
Sigoillot-Claude, Cécile Oullins, FR 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00